SME Equity Research · India
We track 300+ SME companies to surface the finest 15–20 high-growth, investable ideas with a clear moat.
An independent, bottom-up research desk covering the least-analysed listed businesses in India — the BSE SME and NSE Emerge universe, where sell-side coverage is close to absent and the price often lags the facts by quarters.
Awaiting SEBI Research Analyst licence · Published for information and education only
01The opportunity
Where the market looks away
India's listed universe has grown far faster than the research capacity aimed at it. Over a thousand SMEs now report quarterly numbers, hold concalls and publish annual reports that almost nobody reads.
Attention concentrates at the top
Institutional flows, media coverage and broker notes cluster around a few hundred well-known names. Everything below that band competes for a shrinking pool of analyst hours.
The SME universe is structurally overlooked
Free float is small, lot sizes are awkward and most mandates simply cannot hold these companies. Fewer eyes means information travels slowly and gets priced late.
Nobody has bandwidth for 300+ concalls a quarter
Reading that many transcripts, tracing guidance against delivery and re-reading last year's promises is grinding, unglamorous work. It is also where most of the signal lives.
0+
Listed SMEs across BSE SME and NSE Emerge as of February 2026 — a universe larger than the entire mainboard mid-cap segment, with a fraction of the coverage.
This coverage gap is precisely where we operate.
We do not try to out-model the market on a widely-held large cap. We go where the primary documents have barely been read, and we read them.
02The filter
From 300 names to 15–20 convictions
A disciplined, repeatable funnel. Each stage removes names for a stated reason, so the shortlist can always be traced back to the test a company passed rather than the story it told.
- Universe300
SMEs actively tracked, with a maintained financial history and a watch status.
- Quality filters250
Balance-sheet and governance screens. Names with unexplained accounting or promoter red flags leave here.
- Growth filters120
Earnings and demand momentum. What remains is growing for a reason we can point at.
- Research candidates60
The deep-dive shortlist — names that earn the full seven-section note and a set of concall checkpoints.
- High-conviction ideas15–20
Portfolio-ready. A defensible business at a defensible price, with the risks written down.
Roughly one name in twenty survives the whole sequence.
03The thesis
Why SMEs?
Four structural inefficiencies, all persistent rather than cyclical. Together they create a repeatable edge for disciplined, bottom-up research — not a one-off trade.
04Research universe
300+ SMEs, continuously tracked
Coverage is not a list we publish once. It is a live universe: every name carries a financial history, a filter status and a watch flag that gets revisited on every result and every concall.
By sector · illustrative mix
- ManufacturingPrecision components, castings, process equipment35%
- IndustrialsPower T&D, water, infrastructure supply chains20%
- New age businessesPlatform, D2C and asset-light service models15%
- ConsumerBranded goods, ingredients, specialty formulations15%
- TechnologyEnterprise software, IT services, cybersecurity15%
Track first, opine later
A name enters the universe long before it earns a view. We build the history, watch two or three reporting cycles, and only then decide whether it deserves a full note.
Manufacturing-heavy by design
The mix is an outcome, not a target. Physical businesses with certifications, plants and repeat orders leave a verifiable paper trail — which is what makes them researchable.
Silence is a valid output
Where disclosure is thin or the numbers are not yet trustworthy, the note ends with what we are waiting for and a date. A rating we cannot defend is worth less than no rating.
05Investment framework
What we look for in every high-conviction idea
Six tests, applied to every name that reaches the shortlist. A company need not pass all six perfectly — but we write down where it fails, and a failure on promoter quality or valuation discipline usually ends the discussion.
Niche businesses
Defensible, specialised offerings with genuine pricing power — products where the customer's cost of switching is real, not rhetorical.
- Approvals, certifications or qualification cycles
- Share of a narrow category, not a broad market
- Evidence that price is set rather than accepted
Strong financial execution
Consistent revenue and margin delivery on a clean balance sheet. Growth that arrives with cash attached, not only with revenue recognition.
- Operating cash flow tracking reported profit
- Working-capital days stable as revenue scales
- Debt serviced from operations, not refinancing
Promoter quality
Capable, aligned management with real skin in the game — and a record of saying what they will do, then doing it.
- Holding maintained rather than quietly sold down
- Related-party dealings small and explicable
- Prior guidance checked against prior delivery
Capacity expansion
Funded growth in capacity that plausibly drives the next leg — with a commissioning date we can hold management to.
- Funding already in hand, not merely planned
- Utilisation on existing lines high enough to justify it
- Demand identified before capacity is added
Industry tailwinds
Structural demand with visible near-term triggers — a sector where the spending decision has already been made by someone with a budget.
- Policy, capex cycle or import-substitution driver
- Positioned in the path of the spend, not near it
- Trigger dated, not indefinitely "coming"
Valuation discipline
Growth at a sensible price, with a real margin of safety. A good business bought carelessly is still a bad investment.
- Value triangulated across more than one method
- Downside case priced, not just the base case
- Willingness to pass on a name we like at a price we don't
06Our process
How research is conducted
A repeatable six-stage pipeline from raw screen to conviction. The order is fixed on purpose — valuation comes last, so that a cheap price never becomes the reason we tolerate a weak business.
Growth scanner
A first pass across the tracked universe to remove names with no execution history — erratic revenue, unexplained losses, or growth that exists only in a forecast. The purpose here is subtraction: get from 300 names to a set worth spending real hours on.
Financial stress-testing
Pressure-test the balance sheet and cash flows. Receivable and inventory days across cycles, operating cash flow against reported profit, debt maturity against cash generation. Where accounting choices flatter the picture, we normalise and show both versions.
Concall & guidance analysis
Read the transcripts, then read last year's transcripts. We separate what management guided from what management delivered, and note which specific claims are testable in the next two quarters. Promised numbers become checkpoints, not colour.
Industry mapping
Size the opportunity and identify the underlying demand driver — the policy, capex cycle or substitution trend actually paying the bills. This is also where we test whether a company is genuinely exposed to a theme or merely adjacent to it.
Competitor study
Benchmark moat, market share and positioning against listed and unlisted peers. Margins are compared like for like, and we ask the uncomfortable question directly: what stops a well-funded competitor from doing this next year?
Valuation analysis
Only now does price enter. Fair value is triangulated across methods, a downside case is built explicitly, and the note states the level at which the thesis stops being attractive. If there is no margin of safety, the output is a watch flag rather than a rating.
07Sample research
Published notes
Every note runs the same seven sections: introduction, business model, moat, tailwinds, financial deep dive, management commentary and key risks. Read them here in full — nothing opens in a new tab.
Indo SMC Limited
Power Distribution · Smart Metering
BSE SME 544681 · Ahmedabad
What the note covers
An SMC/FRP and CT-PT specialist sitting at the equipment layer of India’s distribution build-out, with revenue compounding from ₹7 Cr in FY23 to ₹310 Cr in FY26 on RDSS smart-metering demand. Approved-vendor status is the moat. The binding constraint is cash: operating cash flow was negative through FY25, so the whole thesis turns on conversion rather than growth.
Yash Highvoltage Limited
Power T&D · Electrical Equipment
BSE SME 544310 · Vadodara
What the note covers
India’s only listed independent bushings pure-play — a component worth 1–3% of a transformer’s cost whose failure takes the whole unit down, which is what makes it mission-critical rather than commodity. Three separate growth vectors: the IPO-funded Savli RIP plant, the 50:50 Sukrut JV, and exports realising 30–40% above domestic. Execution risk sits squarely on the capacity timeline.
Sacheerome Limited
Fragrances & Flavours · B2B FMCG
NSE SME SACHEEROME
What the note covers
A B2B fragrance and flavour compounder — blends specified into a customer’s own product, which makes reformulation costly and revenue sticky. Genuinely clean for an SME: ~24% EBITDA margin, ~36% ROCE, debt-free, cash-conversion cycle cut from 109 days to 34. The swing factor is a ₹184 Cr YEIDA capex against a ₹62 Cr IPO.
Reports open in a reader on this page · nothing leaves the site
Published for information and education · not investment advice
08What you receive
Deliverables, every quarter
Three outputs on a fixed cadence. The intent is that a client never has to ask what changed — the new ideas, the management commentary and the tracker all arrive together and reconcile with each other.
Quarterly · 5–10 ideas
High-conviction research ideas
Full-length initiation notes on the names that survive the six-stage process, written in the same fixed structure so two notes can be read against each other.
- Business model, moat and industry tailwind, stated plainly
- Financial deep dive with accounting distortions normalised
- Management commentary checked against prior delivery
- Valuation range, base target and the level where the thesis breaks
- Key risks written as specific falsifiable events, not disclaimers
Quarterly · across the universe
Concall notes
Distilled management commentary and forward guidance from across the tracked universe — the reading that nobody has bandwidth to do at this scale.
- Guidance extracted and dated, so it can be tested later
- Delivery against the previous quarter's promises
- Changes in tone, capacity plans and customer concentration
- Flagged contradictions between the call and the filings
Living document · 300+ names
SME tracker
The working file behind the research: every tracked company with its financial history, filter status and watch flag, updated as results land.
- Revenue, margin, cash-flow and balance-sheet history per name
- Which quality and growth filters each name currently passes
- Watch status — tracked, shortlisted, under review or rated
- Sector grouping, so exposure can be seen at a glance
09Who this is for
Built for serious allocators
An institutional-grade SME research desk for those who allocate with conviction — and for individual investors who would rather read the work than the headline.
AIFs
Alternative funds
Idea flow and a maintained tracker for CAT II and III funds running SME or small-cap mandates without a dedicated internal desk.
RIAs
Registered advisors
Documented, independent research you can reference in client conversations, with the risks written down as clearly as the upside.
Wealth managers
Private wealth
A satellite allocation sleeve with genuine research behind it, for clients who want exposure beyond the standard mainboard shortlist.
Family offices
Long-term capital
Patient capital is the right holder of illiquid SME positions. We supply the depth of work that a multi-year holding period deserves.
PMS firms
Portfolio managers
Bottom-up initiation notes and concall coverage that extend an existing team's reach into a universe it cannot staff.
MFDs
Mutual fund distributors
Sector primers and plain-language notes that make an under-covered segment explainable to clients who are new to it.
Individual investors
Retail & HNI
The full note rather than a tip — including the names where our conclusion was to wait, and the reasoning behind that.
Not sure which you are?
Start here
Tell us how you allocate and what you are looking at, and we will send the notes that are actually relevant.
10About the analyst
Tarun Garg
Lead Analyst, Triple Arrow Capital. A bottom-up SME stock specialist — the research on this site is written, not compiled.
MBA in Finance — FLAME University
Formal training in valuation and financial analysis, applied since to the least-covered end of the listed market.
6 years of investing experience
Six years of active market experience across cycles, with the last several concentrated on the SME and emerging small-cap segment.
Equity research analyst at an SME-focused CAT III AIF
A year covering SMEs institutionally for the MAIQ Growth Scheme and Strategic Sixth Sense Fund — building the screens, sitting on the concalls and defending ideas in front of a committee.
Bottom-up SME stock specialist
Primary documents first: annual reports, RHPs, transcripts and plant-level detail — then the model, then the price.
Investment philosophy
Quality before conviction, and conviction before size. A business has to survive the balance-sheet and promoter tests before its growth story is allowed to be interesting. Most names fail here, and that is the point of the funnel.
Valuation comes last, deliberately. Looking at price early is how a cheap multiple starts excusing a weak business. Running the sequence in a fixed order keeps that from happening.
Write down what would make it wrong. Every note ends with specific, falsifiable risks and, where the evidence is not yet there, a date to revisit. Waiting is a legitimate output.
Why SMEs, specifically
Because this is the one part of the Indian market where careful reading still gets paid. In a widely-covered large cap, the twentieth analyst adds nothing. In a company with no maintained model and one lightly-attended concall a quarter, the first person to do the work properly holds a real informational edge — and that edge comes from effort rather than access.
11Associate with us
Associate With Us & Get Access to the Best SME Investing Ideas
Leave your details below and we’ll get in touch to understand your investment approach and discuss how our institutional-quality SME research can add value to your process.
- Research desk
- Lead analyst
- Phone
- X
- Office
N-26, First Floor, Kalkaji, New Delhi 110019
- GSTIN
07DETPG6136P1ZP
- SEBI RA Licence
In process